{
    "body": "Which genes are associated with Ehlers-Danlos syndrome type I/II?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/10796876", 
        "http://www.ncbi.nlm.nih.gov/pubmed/8923000", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9425231", 
        "http://www.ncbi.nlm.nih.gov/pubmed/8541855", 
        "http://www.ncbi.nlm.nih.gov/pubmed/8752669", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9783710", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12145749", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9499606", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20847697"
    ], 
    "ideal_answer": [
        "It is currently estimated that approximately 50% of patients with a clinical diagnosis of classic Ehlers-Danlos syndrome harbor mutations in the COL5A1 and the COL5A2 gene, encoding the \u03b11 and the \u03b12-chain of type V collagen, respectively", 
        "Ehlers-Danlos syndrome (EDS) type I (the classical variety) is a dominantly inherited, genetically heterogeneous connective-tissue disorder. Mutations in the COL5A1 and COL5A2 genes, which encode type V collagen, have been identified in several individuals. Most mutations affect either the triple-helical domain of the protein or the expression of one COL5A1 allele  It is currently estimated that approximately 50% of patients with a clinical diagnosis of classic Ehlers-Danlos syndrome harbor mutations in the COL5A1 and the COL5A2 gene, encoding the \u03b11 and the \u03b12-chain of type V collagen, respectively  ", 
        "It is currently estimated that approximately 50% of patients with a clinical diagnosis of classic Ehlers-Danlos syndrome harbor mutations in the COL5A1 and the COL5A2 gene, encoding the \u03b11 and the \u03b12-chain of type V collagen, respectively.", 
        "Ehlers-Danlos syndrome (EDS) type I (the classical variety) is a dominantly inherited, genetically heterogeneous connective-tissue disorder. Mutations in the COL5A1 and COL5A2 genes, which encode type V collagen, have been identified in several individuals. Most mutations affect either the triple-helical domain of the protein or the expression of one COL5A1 allele  "
    ], 
    "exact_answer": [
        [
            "COL5A1"
        ], 
        [
            "COL5A2"
        ]
    ], 
    "concepts": [
        "http://www.disease-ontology.org/api/metadata/DOID:14720", 
        "http://www.disease-ontology.org/api/metadata/DOID:13359"
    ], 
    "type": "list", 
    "id": "54e22b62ae9738404b000011", 
    "snippets": [
        {
            "offsetInBeginSection": 437, 
            "offsetInEndSection": 675, 
            "text": "It is currently estimated that approximately 50% of patients with a clinical diagnosis of classic Ehlers-Danlos syndrome harbor mutations in the COL5A1 and the COL5A2 gene, encoding the \u03b11 and the \u03b12-chain of type V collagen, respectively", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20847697", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 954, 
            "offsetInEndSection": 1176, 
            "text": "In the majority of patients with molecularly characterized classic Ehlers-Danlos syndrome, the disease is caused by a mutation leading to a nonfunctional COL5A1 allele and resulting in haploinsufficiency of type V collagen", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20847697", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1178, 
            "offsetInEndSection": 1335, 
            "text": "A smaller proportion of patients harbor a structural mutation in COL5A1 or COL5A2, causing the production of a functionally defective type V collagen protein", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20847697", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 209, 
            "text": "Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12145749", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 366, 
            "text": "Ehlers-Danlos syndrome (EDS) type I (the classical variety) is a dominantly inherited, genetically heterogeneous connective-tissue disorder. Mutations in the COL5A1 and COL5A2 genes, which encode type V collagen, have been identified in several individuals. Most mutations affect either the triple-helical domain of the protein or the expression of one COL5A1 allele", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12145749", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 368, 
            "offsetInEndSection": 506, 
            "text": "We identified a novel splice-acceptor mutation (IVS4-2A-->G) in the N-propeptide-encoding region of COL5A1, in one patient with EDS type I", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12145749", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 116, 
            "text": "Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type I", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9425231", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 169, 
            "offsetInEndSection": 332, 
            "text": "We have identified mutations of the COL5A2 gene, which encodes the alpha2(V) chain of type V collagen, in two unrelated patients with the severe type I form of EDS", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9425231", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1082, 
            "offsetInEndSection": 1183, 
            "text": "Our findings show that heterozygous mutations of the COL5A2 gene can produce the EDS type I phenotype", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9425231", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 180, 
            "text": "A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I)", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8923000", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 267, 
            "offsetInEndSection": 449, 
            "text": "We report that genomic polymorphisms at the pro alpha 1(V) gene (COL5A1) locus cosegregated with the gravis form of Ehlers-Danlos syndrome (EDS) (type I) in a three generation family", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8923000", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 730, 
            "offsetInEndSection": 965, 
            "text": "Since exon 65 encodes 78 residues of the carboxyl propeptide, the expected result of this mutation is reduced efficiency in incorporating mutant pro alpha 1(V) chains into type V collagen molecules and reduced type V collagen synthesis", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8923000", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 967, 
            "offsetInEndSection": 1052, 
            "text": "These studies indicate that heterozygous mutations in COL5A1 can result in EDS type I", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8923000", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 96, 
            "text": "The gene encoding collagen alpha1(V)(COL5A1) is linked to mixed Ehlers-Danlos syndrome type I/II", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8752669", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 386, 
            "offsetInEndSection": 552, 
            "text": "Recently, genetic linkage has been demonstrated between the COL5A1 gene, which encodes the alphal chain of type V collagen, and EDS type II in a large British kindred", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8752669", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 554, 
            "offsetInEndSection": 707, 
            "text": "Using a polymorphic intragenic simple sequence repeat at the COL5A1 locus, we now demonstrate tight linkage to EDS type I/II in a three-generation family", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8752669", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 791, 
            "offsetInEndSection": 974, 
            "text": "The variation in expression in this family suggests that EDS types I and II are allelic, and the linkage data support the hypothesis that mutation in COL5A1 can cause both phenotypes.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8752669", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 129, 
            "text": "Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II).", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10796876", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 85, 
            "offsetInEndSection": 230, 
            "text": "Recently mutations have been found in the genes for type V collagen in a small number of people with the most common forms of EDS, types I and II", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9783710", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 97, 
            "text": "The gene encoding collagen alpha1(V)(COL5A1) is linked to mixed Ehlers-Danlos syndrome type I/II.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8752669", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 122, 
            "text": "Linkage of the gene that encodes the alpha 1 chain of type V collagen (COL5A1) to type II Ehlers-Danlos syndrome (EDS II).", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8541855", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 144, 
            "text": "Genetic linkage to the collagen alpha 1 (V) gene (COL5A1) in two British Ehlers-Danlos syndrome families with variable type I and II phenotypes.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9499606", 
            "endSection": "title"
        }
    ]
}